Literature DB >> 19739238

Randomization by minimization for unbalanced treatment allocation.

Baoguang Han1, Nathan H Enas, Damian McEntegart.   

Abstract

Minimization is a dynamic randomization technique that has been widely used in clinical trials for achieving a balance of prognostic factors across treatment groups, but most often it has been used in the setting of equal treatment allocations. Although unequal treatment allocation is frequently encountered in clinical trials, an appropriate minimization procedure for such trials has not been published. The purpose of this paper is to present novel strategies for applying minimization methodology to such clinical trials. Two minimization techniques are proposed and compared by probability calculation and simulation studies. In the first method, called naïve minimization, probability assignment is based on a simple modification of the original minimization algorithm, which does not account for unequal allocation ratios. In the second method, called biased-coin minimization (BCM), probability assignment is based on allocation ratios and optimized to achieve an 'unbiased' target allocation ratio. The performance of the two methods is investigated in various trial settings including different number of treatments, prognostic factors and sample sizes. The relative merits of the different distance metrics are also explored. On the basis of the results, we conclude that BCM is the preferable method for randomization in clinical trials involving unequal treatment allocations. The choice of different distance metrics slightly affects the performance of the minimization and may be optimized according to the specific feature of trials.

Entities:  

Mesh:

Year:  2009        PMID: 19739238     DOI: 10.1002/sim.3710

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  31 in total

1.  A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.

Authors:  Alba A Brandes; Antoine F Carpentier; Santosh Kesari; Juan M Sepulveda-Sanchez; Helen R Wheeler; Olivier Chinot; Lawrence Cher; Joachim P Steinbach; David Capper; Pol Specenier; Jordi Rodon; Ann Cleverly; Claire Smith; Ivelina Gueorguieva; Colin Miles; Susan C Guba; Durisala Desaiah; Michael M Lahn; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2016-02-21       Impact factor: 12.300

2.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

3.  Ranking evidence in substance use and addiction.

Authors:  Hudson Reddon; Thomas Kerr; M-J Milloy
Journal:  Int J Drug Policy       Date:  2020-07-06

4.  Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Authors:  N Lechtzin; N West; S Allgood; E Wilhelm; U Khan; N Mayer-Hamblett; M L Aitken; B W Ramsey; M P Boyle; P J Mogayzel; C H Goss
Journal:  Contemp Clin Trials       Date:  2013-09-19       Impact factor: 2.226

5.  Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology.

Authors:  Adnan I Qureshi; Foad Abd-Allah; Aitziber Aleu; John J Connors; Ricardo A Hanel; Ameer E Hassan; Haitham M Hussein; Nazli A Janjua; Rakesh Khatri; Jawad F Kirmani; Mikael Mazighi; Heinrich P Mattle; Jefferson T Miley; Thanh N Nguyen; Gustavo J Rodriguez; Qaisar A Shah; Adnan H Siddiqui; Jose I Suarez; M Fareed K Suri; Reha Tolun
Journal:  J Vasc Interv Neurol       Date:  2014-05

6.  A weight-loss Mediterranean diet/lifestyle intervention ameliorates inflammation and oxidative stress in patients with obstructive sleep apnea: results of the "MIMOSA" randomized clinical trial.

Authors:  Michael Georgoulis; Nikos Yiannakouris; Roxane Tenta; Elizabeth Fragopoulou; Ioanna Kechribari; Kallirroi Lamprou; Eleni Perraki; Emmanοuil Vagiakis; Meropi D Kontogianni
Journal:  Eur J Nutr       Date:  2021-04-10       Impact factor: 5.614

7.  Assessment of Leg Massage on Hemodynamic Parameters of Intensive Care Patients: A Parallel Single-Blinded Randomized Controlled Trial.

Authors:  Masoumeh Momeni; Mansour Arab; Mahlagha Dehghan; Mehdi Ahmadinejad
Journal:  J Chiropr Med       Date:  2020-09-04

8.  Dynamic randomization and a randomization model for clinical trials data.

Authors:  Lee D Kaiser
Journal:  Stat Med       Date:  2012-07-05       Impact factor: 2.373

Review 9.  Allocation techniques for balance at baseline in cluster randomized trials: a methodological review.

Authors:  Noah M Ivers; Ilana J Halperin; Jan Barnsley; Jeremy M Grimshaw; Baiju R Shah; Karen Tu; Ross Upshur; Merrick Zwarenstein
Journal:  Trials       Date:  2012-08-01       Impact factor: 2.279

10.  Electrophysiological predictors and indicators of contingency management treatment response: Rationale and design for the ways of rewarding abstinence project (WRAP).

Authors:  Sarah E Forster; Steven D Forman; Naomi N Gancz; Greg J Siegle; Michael Walsh Dickey; Stuart R Steinhauer
Journal:  Contemp Clin Trials Commun       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.